Stem cell science is an area of medical research that continues to offer great promise. But as this week’s paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, are exploiting regulatory gaps to sell so-called stem cell treatments without evidence that what they offer is effective – or even safe.
Such unregulated direct-to-consumer advertising – typically of cells obtained using liposuction-like methods – not only places the health of individuals at risk but could also undermine the legitimate development of stem cell-based therapies.
Many academic societies and professional medical organisations have